Annexin A2 as a mediator of pancreatic cancer metastases
膜联蛋白 A2 作为胰腺癌转移的介质
基本信息
- 批准号:8712421
- 负责人:
- 金额:$ 32.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-08-02 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:ANXA2 geneAdenocarcinoma CellAdoptedAnnexinsAntigensBindingCell LineCell surfaceCellsClinicalCoculture TechniquesCommunicationComplexCytosolDevelopmentDiseaseDrug resistanceEffectivenessEpithelialEpitheliumErinaceidaeEventFibroblastsGene ChipsGenesGoalsHepatocyte Growth FactorHumanIn VitroInsulin-Like Growth Factor IInsulin-Like-Growth Factor I ReceptorInterventionInvestigationKnock-in MouseKnock-outKnockout MiceLesionLinkLymphaticMalignant NeoplasmsMalignant neoplasm of pancreasMediatingMediator of activation proteinMesenchymalMesenchymal Stem CellsMusMutationNeoplasm MetastasisOutcomePancreatic Ductal AdenocarcinomaPathogenesisPathway interactionsPhosphoproteinsPhosphorylationPremalignantProcessPublishingRoleSRC geneSignal PathwaySignal TransductionStromal CellsSupporting CellSurfaceSystemTestingTissuesTransforming Growth Factor betaTyrosineTyrosine Phosphorylationaxon guidancecell motilitycell stromaeffective therapyepithelial to mesenchymal transitionextracellularimprovedin vivoinhibitor/antagonistmeetingsmouse modelmutantneoplastic cellnew therapeutic targetnovelpancreatic neoplasmparacrineperineuralpublic health relevancereceptorresearch studyresponserhosmoothened signaling pathwaysrc-Family Kinasestumortumor microenvironmenttumor progression
项目摘要
DESCRIPTION (provided by applicant): Pancreatic ductal adenocarcinoma (PDA) metastases are poorly understood, limiting the effectiveness of current treatments. An improved understanding of the mechanisms by which PDA metastasizes is critical for the development of effective treatments specific for this disease. We recently identified a PDA-associated antigen, annexin A2 (ANXA2), and demonstrated that tyrosine 23-phosphorylation-dependent cell-surface translocation of ANXA2 is critical for TGFbeta-Rho mediated epithelia-to-mesenchymal transition, invasion and metastasis of PDAs. This proposal aims to delineate the upstream and downstream pathways of ANXA2 to achieve our ultimate goal of identifying new therapeutic targets for PDA treatment. In particular, we hypothesize that two paracrine stromal-to-epithelial axes - the Hedgehog-Insulin-like growth factor I receptor pathway and the hepatocyte growth factor/c-met signaling - form a functional link between PDA stroma and epithelial compartments, resulting in ANXA2 phosphorylation. To understand the effector pathways whereby PDA metastases are promoted following the activation of ANXA2 by phosphorylation, our preliminary studies have led to the second part of our hypothesis that ANXA2 regulates PDA invasion and metastasis through Sema3d/Plxnd1, both belonging to an axon guidance pathway. We therefore propose two aims to test these hypotheses. Specific Aim 1 will elucidate the network of signals that originate in the stroma and result in ANXA2 translocation to the surface of PDA cells. Specific Aim 2 will delineate the downstream effectors of ANXA2 within PDA tumor cells that mediate metastatic spread through axon guidance molecules. The end result will be the elucidation of the complex network of signals that results in cross-talk between the PDA and its microenvironment, and that are mediated through ANXA2 to control PDA invasion and metastasis formation. This in turn, will provide new targets against which to develop novel interventions that disrupt the communication, and in doing so, abrogate tumor progression and metastases.
描述(由申请人提供):胰腺导管腺癌(PDA)转移的了解很少,限制了目前治疗的有效性。进一步了解PDA转移的机制对于开发针对这种疾病的有效治疗方法至关重要。我们最近发现了一种PDA相关抗原,膜联蛋白A2(ANXA 2),并证明ANXA 2的酪氨酸23磷酸化依赖性细胞表面易位对于TGFbeta-Rho介导的上皮至间充质转化、PDA的侵袭和转移至关重要。该提案旨在描述ANXA 2的上游和下游途径,以实现我们的最终目标,即确定PDA治疗的新治疗靶点。特别是,我们假设两个旁分泌基质-上皮轴-刺猬胰岛素样生长因子I受体途径和肝细胞生长因子/c-met信号传导-在PDA基质和上皮隔室之间形成功能性联系,导致ANXA 2磷酸化。为了了解ANXA 2通过磷酸化激活后促进PDA转移的效应途径,我们的初步研究导致了我们假设的第二部分,即ANXA 2通过Sema 3d/Plxnd 1调节PDA侵袭和转移,两者都属于轴突导向途径。因此,我们提出了两个目标来测试这些假设。特异性目的1将阐明起源于基质并导致ANXA 2易位至PDA细胞表面的信号网络。特异性目标2将描绘PDA肿瘤细胞内ANXA 2的下游效应物,其通过轴突引导分子介导转移性扩散。最终结果将是阐明导致PDA与其微环境之间的串扰的复杂信号网络,以及通过ANXA 2介导以控制PDA侵袭和转移形成的信号网络。这反过来将提供新的靶点,以开发新的干预措施来破坏通信,并在此过程中消除肿瘤进展和转移。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lei Zheng其他文献
Lei Zheng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lei Zheng', 18)}}的其他基金
Integration of stromal targeting agents with immune checkpoint therapy
基质靶向剂与免疫检查点疗法的整合
- 批准号:
10408084 - 财政年份:2021
- 资助金额:
$ 32.61万 - 项目类别:
Structure and function of a metabolic pacemaker in bacterial cell membrane
细菌细胞膜代谢起搏器的结构和功能
- 批准号:
10280369 - 财政年份:2021
- 资助金额:
$ 32.61万 - 项目类别:
Structure and function of a metabolic pacemaker in bacterial cell membrane
细菌细胞膜代谢起搏器的结构和功能
- 批准号:
10652472 - 财政年份:2021
- 资助金额:
$ 32.61万 - 项目类别:
Structure and function of a metabolic pacemaker in bacterial cell membrane
细菌细胞膜代谢起搏器的结构和功能
- 批准号:
10457395 - 财政年份:2021
- 资助金额:
$ 32.61万 - 项目类别:
Integration of stromal targeting agents with immune checkpoint therapy
基质靶向剂与免疫检查点疗法的整合
- 批准号:
10661808 - 财政年份:2021
- 资助金额:
$ 32.61万 - 项目类别:
Structure and function of a metabolic pacemaker in bacterial cell membrane
细菌细胞膜代谢起搏器的结构和功能
- 批准号:
10796719 - 财政年份:2021
- 资助金额:
$ 32.61万 - 项目类别:
Annexin A2 as a mediator of pancreatic cancer metastases
膜联蛋白 A2 作为胰腺癌转移的介质
- 批准号:
8579467 - 财政年份:2013
- 资助金额:
$ 32.61万 - 项目类别:
Interrogate the interaction between tumor cells and nerves in the tumor microenvironment of pancreatic cancer
探究胰腺癌肿瘤微环境中肿瘤细胞与神经之间的相互作用
- 批准号:
9764752 - 财政年份:2013
- 资助金额:
$ 32.61万 - 项目类别:
Interrogate the interaction between tumor cells and nerves in the tumor microenvironment of pancreatic cancer
探究胰腺癌肿瘤微环境中肿瘤细胞与神经之间的相互作用
- 批准号:
10578764 - 财政年份:2013
- 资助金额:
$ 32.61万 - 项目类别:
Interrogate the interaction between tumor cells and nerves in the tumor microenvironment of pancreatic cancer
探究胰腺癌肿瘤微环境中肿瘤细胞与神经之间的相互作用
- 批准号:
10358637 - 财政年份:2013
- 资助金额:
$ 32.61万 - 项目类别:
相似海外基金
Assessing The Impact of Heparanase and NDST2 Expression on Non-Small Cell Lung Adenocarcinoma Cell Motility
评估乙酰肝素酶和 NDST2 表达对非小细胞肺腺癌细胞运动的影响
- 批准号:
449570 - 财政年份:2020
- 资助金额:
$ 32.61万 - 项目类别:
Studentship Programs
Analysis of cancer metastasis and invasion mechanism using a new lung adenocarcinoma cell line.
使用新的肺腺癌细胞系分析癌症转移和侵袭机制。
- 批准号:
16K10689 - 财政年份:2016
- 资助金额:
$ 32.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Acquisition strategy of tumor-specific markers using established micropapillary pattern pulmonary adenocarcinoma cell line
使用已建立的微乳头模式肺腺癌细胞系获取肿瘤特异性标志物的策略
- 批准号:
26460441 - 财政年份:2014
- 资助金额:
$ 32.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The antibetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo.
抗生素药物二甲双胍在体外和体内抑制食管腺癌细胞增殖。
- 批准号:
25860540 - 财政年份:2013
- 资助金额:
$ 32.61万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
The cell permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferations and can be used as the molecular targeting dru
细胞通透肽抑制胰腺导管腺癌细胞增殖,可作为分子靶向药物
- 批准号:
25461969 - 财政年份:2013
- 资助金额:
$ 32.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Basic Research for elucidation of chemo-resistance in mucinous adenocarcinoma cell.
阐明粘液腺癌细胞化疗耐药性的基础研究。
- 批准号:
22791532 - 财政年份:2010
- 资助金额:
$ 32.61万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
TAS::75 0849::TAS IN THIS PHASE I SBIR THE BREAST CANCER ADENOCARCINOMA CELL LI
TAS::75 0849::TAS 在这一阶段 I SBIR 乳腺癌腺癌细胞 LI
- 批准号:
8164743 - 财政年份:2010
- 资助金额:
$ 32.61万 - 项目类别:
Role of Endothelin-1 in osteoblastic bone metastasis produced by a human lung adenocarcinoma cell line
Endothelin-1 在人肺腺癌细胞系产生的成骨细胞骨转移中的作用
- 批准号:
19790127 - 财政年份:2007
- 资助金额:
$ 32.61万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
CONNEXIN 43 EXPRESSION IN ADENOCARCINOMA CELL LINE
连接蛋白 43 在腺癌细胞系中的表达
- 批准号:
6972483 - 财政年份:2004
- 资助金额:
$ 32.61万 - 项目类别:
The mechanisms of highly metastetic capasity in highly metastatic subpopulations of lung adenocarcinoma cell line and these clinical applications
肺腺癌细胞系高转移亚群的高转移能力机制及临床应用
- 批准号:
15590831 - 财政年份:2003
- 资助金额:
$ 32.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)